Global and United States Tyrosine Kinase JAK Inhibitors Market Research by Company, Type & Application 2013-2025
SUMMARY
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
Market Segment as follows:
By Type
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
Market Segment as follows:
By Type
- Tofacitinib
- Ruxolitinib
- Baricitinib
- Rheumatoid Arthritis (RA)
- Polycythemia Vera (PCV)
- Myelofibrosis (MF)
- Others
- Pfizer
- Incyte
- Novartis
- Eli Lilly
- Gilead
- Sanofi
- Galapagos
- AbbVie
- Vertex
- Teva
- Astellas Pharma
- Celgene
- CTI BioPharma
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 MARKET OVERVIEW
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Tofacitinib
1.1.2.2 Ruxolitinib
1.1.2.3 Baricitinib
1.1.3 Market by Application
1.1.3.1 Rheumatoid Arthritis (RA)
1.1.3.2 Polycythemia Vera (PCV)
1.1.3.3 Myelofibrosis (MF)
1.1.3.4 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 Pfizer
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Incyte
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Novartis
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Eli Lilly
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Gilead
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Sanofi
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Galapagos
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 AbbVie
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Vertex
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Teva
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Astellas Pharma
6.12 Celgene
6.13 CTI BioPharma
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Tofacitinib
1.1.2.2 Ruxolitinib
1.1.2.3 Baricitinib
1.1.3 Market by Application
1.1.3.1 Rheumatoid Arthritis (RA)
1.1.3.2 Polycythemia Vera (PCV)
1.1.3.3 Myelofibrosis (MF)
1.1.3.4 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 Pfizer
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Incyte
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Novartis
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Eli Lilly
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Gilead
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Sanofi
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Galapagos
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 AbbVie
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Vertex
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Teva
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Astellas Pharma
6.12 Celgene
6.13 CTI BioPharma
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
LIST OF TABLES
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of Incyte
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly
Table Sales Revenue, Volume, Price, Cost and Margin of Gilead
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Table Sales Revenue, Volume, Price, Cost and Margin of Galapagos
Table Sales Revenue, Volume, Price, Cost and Margin of AbbVie
Table Sales Revenue, Volume, Price, Cost and Margin of Vertex
Table Sales Revenue, Volume, Price, Cost and Margin of Teva
Table Sales Revenue, Volume, Price, Cost and Margin of Astellas Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Celgene
Table Sales Revenue, Volume, Price, Cost and Margin of CTI BioPharma
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of Incyte
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly
Table Sales Revenue, Volume, Price, Cost and Margin of Gilead
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Table Sales Revenue, Volume, Price, Cost and Margin of Galapagos
Table Sales Revenue, Volume, Price, Cost and Margin of AbbVie
Table Sales Revenue, Volume, Price, Cost and Margin of Vertex
Table Sales Revenue, Volume, Price, Cost and Margin of Teva
Table Sales Revenue, Volume, Price, Cost and Margin of Astellas Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Celgene
Table Sales Revenue, Volume, Price, Cost and Margin of CTI BioPharma
LIST OF FIGURES
Figure Tofacitinib Market Size and CAGR 2013-2017 (Million USD)
Figure Tofacitinib Market Size and CAGR 2013-2017 (Volume)
Figure Tofacitinib Market Forecast and CAGR 2018-2025 (Million USD)
Figure Tofacitinib Market Forecast and CAGR 2018-2025 (Volume)
Figure Ruxolitinib Market Size and CAGR 2013-2017 (Million USD)
Figure Ruxolitinib Market Size and CAGR 2013-2017 (Volume)
Figure Ruxolitinib Market Forecast and CAGR 2018-2025 (Million USD)
Figure Ruxolitinib Market Forecast and CAGR 2018-2025 (Volume)
Figure Baricitinib Market Size and CAGR 2013-2017 (Million USD)
Figure Baricitinib Market Size and CAGR 2013-2017 (Volume)
Figure Baricitinib Market Forecast and CAGR 2018-2025 (Million USD)
Figure Baricitinib Market Forecast and CAGR 2018-2025 (Volume)
Figure Rheumatoid Arthritis (RA) Market Size and CAGR 2013-2017 (Million USD)
Figure Rheumatoid Arthritis (RA) Market Size and CAGR 2013-2017 (Volume)
Figure Rheumatoid Arthritis (RA) Market Forecast and CAGR 2018-2025 (Million USD)
Figure Rheumatoid Arthritis (RA) Market Forecast and CAGR 2018-2025 (Volume)
Figure Polycythemia Vera (PCV) Market Size and CAGR 2013-2017 (Million USD)
Figure Polycythemia Vera (PCV) Market Size and CAGR 2013-2017 (Volume)
Figure Polycythemia Vera (PCV) Market Forecast and CAGR 2018-2025 (Million USD)
Figure Polycythemia Vera (PCV) Market Forecast and CAGR 2018-2025 (Volume)
Figure Myelofibrosis (MF) Market Size and CAGR 2013-2017 (Million USD)
Figure Myelofibrosis (MF) Market Size and CAGR 2013-2017 (Volume)
Figure Myelofibrosis (MF) Market Forecast and CAGR 2018-2025 (Million USD)
Figure Myelofibrosis (MF) Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure Global Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure Global Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure United States Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure United States Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Tyrosine Kinase JAK Inhibitors SWOT List
Figure Life & Medical Porter's Five Forces
Figure Tofacitinib Market Size and CAGR 2013-2017 (Million USD)
Figure Tofacitinib Market Size and CAGR 2013-2017 (Volume)
Figure Tofacitinib Market Forecast and CAGR 2018-2025 (Million USD)
Figure Tofacitinib Market Forecast and CAGR 2018-2025 (Volume)
Figure Ruxolitinib Market Size and CAGR 2013-2017 (Million USD)
Figure Ruxolitinib Market Size and CAGR 2013-2017 (Volume)
Figure Ruxolitinib Market Forecast and CAGR 2018-2025 (Million USD)
Figure Ruxolitinib Market Forecast and CAGR 2018-2025 (Volume)
Figure Baricitinib Market Size and CAGR 2013-2017 (Million USD)
Figure Baricitinib Market Size and CAGR 2013-2017 (Volume)
Figure Baricitinib Market Forecast and CAGR 2018-2025 (Million USD)
Figure Baricitinib Market Forecast and CAGR 2018-2025 (Volume)
Figure Rheumatoid Arthritis (RA) Market Size and CAGR 2013-2017 (Million USD)
Figure Rheumatoid Arthritis (RA) Market Size and CAGR 2013-2017 (Volume)
Figure Rheumatoid Arthritis (RA) Market Forecast and CAGR 2018-2025 (Million USD)
Figure Rheumatoid Arthritis (RA) Market Forecast and CAGR 2018-2025 (Volume)
Figure Polycythemia Vera (PCV) Market Size and CAGR 2013-2017 (Million USD)
Figure Polycythemia Vera (PCV) Market Size and CAGR 2013-2017 (Volume)
Figure Polycythemia Vera (PCV) Market Forecast and CAGR 2018-2025 (Million USD)
Figure Polycythemia Vera (PCV) Market Forecast and CAGR 2018-2025 (Volume)
Figure Myelofibrosis (MF) Market Size and CAGR 2013-2017 (Million USD)
Figure Myelofibrosis (MF) Market Size and CAGR 2013-2017 (Volume)
Figure Myelofibrosis (MF) Market Forecast and CAGR 2018-2025 (Million USD)
Figure Myelofibrosis (MF) Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure Global Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure Global Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure United States Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure United States Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Tyrosine Kinase JAK Inhibitors SWOT List
Figure Life & Medical Porter's Five Forces
